BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for UNUM THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-16 5:11 pm Purchase |
2020-07-06 | 13G | UNUM THERAPEUTICS INC UMRX |
BIOTECHNOLOGY VALUE FUND L P | 4,154,000 9.990% |
4,154,000 (New Position) |
Filing |